Publications by authors named "Fu Zongchao"
Expert Opin Drug Saf
November 2024
Article Synopsis
- Asfotase alfa (AA) is an FDA-approved treatment for hypophosphatasia, but there is limited data on its side effects in the real world.
- This study analyzed 5,040 adverse events (AEs) related to AA using the U.S. FDA's Adverse Event Reporting System, identifying common issues like injection site reactions and ear/labyrinth disorders.
- The findings suggest that while most AEs are consistent with known data, the newly identified issues warrant further investigation to improve the safety profile of AA.
